AVALO THERAPEUTICS
Avalo Therapeutics is a clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need.
AVALO THERAPEUTICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2011-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.avalotx.com
Total Employee:
11+
Status:
Active
Total Funding:
162.1 M USD
Technology used in webpage:
Euro COVID-19 Amazon Frankfurt Region
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Sio Gene Therapies
Sio Gene Therapies is a clinical-stage biopharmaceutical company.
Caladrius Biosciences
Caladrius Biosciences is a clinical-stage biopharmaceutical company.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Novelion Therapeutics
Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company
SAB Biotherapeutics
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Arch Oncology
Arch Oncology is a venture-stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2024-03-27 | AlmataBio | AlmataBio acquired by Avalo Therapeutics | 15 M USD |
Investors List
Deep Track Capital
Deep Track Capital investment in Post-IPO Equity - Avalo Therapeutics
BVF Partners
BVF Partners investment in Post-IPO Equity - Avalo Therapeutics
Petrichor Healthcare Capital Management
Petrichor Healthcare Capital Management investment in Post-IPO Equity - Avalo Therapeutics
Commodore Capital
Commodore Capital investment in Post-IPO Equity - Avalo Therapeutics
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Avalo Therapeutics
OrbiMed
OrbiMed investment in Post-IPO Equity - Avalo Therapeutics
TCG Crossover
TCG Crossover investment in Post-IPO Equity - Avalo Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2024-06-24 | Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer |
| 2022-01-11 | Avalo Therapeutics Appoints Stephen Smolinski as Chief Commercial Officer |
Official Site Inspections
http://www.avalotx.com Semrush global rank: 1.31 M Semrush visits lastest month: 20.39 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Avalo Therapeutics"
About - AvaloTx - Avalo Therapeutics, Inc.
Under his leadership, his teams provided analytical, formulation, and stability support to all areas of the organization including process development, devices, manufacturing, and quality …See details»
Avalo Therapeutics, Inc. (AVTX) - ir.avalotx.com
Avalo (AVTX) is a clinical stage biotechnology company focused on the treatment of immune mediated inflammatory diseases. Avalo’s lead asset is AVTX-009, an anti-IL-1β mAb, targeting …See details»
Avalo Therapeutics (AVTX) Company Profile & Description
Oct 15, 2015 Company profile for Avalo Therapeutics, Inc. (AVTX) stock, with a description, list of executives, contact details and other key facts.See details»
Avalo Therapeutics - Overview, News & Similar companies
View Avalo Therapeutics (www.avalotx.com) location in Pennsylvania, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Avalo Therapeutics - Crunchbase Company Profile
Avalo Therapeutics is a clinical-stage biopharmaceutical company.Where is Avalo Therapeutics's headquarters? Avalo Therapeutics is located in Rockville, …See details»
Avalo Therapeutics
Feb 25, 2025 Avalo Therapeutics was founded in 2015 with a mission to develop novel therapeutics based on immune cell–directed gene technology. Since then, Avalo has …See details»
Avalo Therapeutics, Inc. - Homepage - AvaloTx
Jun 18, 2025 Avalo is a clinical-stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases. Our lead asset, AVTX-009, is in a Phase 2 clinical trial for hidradenitis …See details»
AVTX - Avalo Therapeutics, Inc. | Company Profile | OTC Markets
Avalo Therapeutics, Inc. 540 Gaither Road Suite 400 Rockville, MD 20850 www.avalotx.com (410) 522-8707 [email protected] Business DescriptionSee details»
Avalo Therapeutics, Inc. Announces Corporate Name Change from …
Aug 26, 2021 Name change underscores the Company’s transition to developing innovative targeted therapies in immunology, immuno-oncology, and rare genetic diseases Robust …See details»
Avalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007 ...
Aug 1, 2022 For more information about Avalo, please visit www.avalotx.com. About Apollo Therapeutics Group Limited Apollo Therapeutics is a biopharmaceutical company, rapidly …See details»
Leadership Team :: Avalo Therapeutics, Inc. (AVTX)
Under his leadership, his teams provided analytical, formulation, and stability support to all areas of the organization including process development, devices, manufacturing, and quality control. Dr. Miano was a key partner of Global …See details»
Board Committees & Governance Documents - ir.avalotx.com
Board Committees & Governance DocumentsCorporate governanceSee details»
Company Information - Avalo Therapeutics, Inc. (AVTX)
Company Profile Avalo (AVTX) is a clinical stage biotechnology company focused on the treatment of immune mediated inflammatory diseases. Avalo’s lead asset is AVTX-009, an anti …See details»
Patients - AvaloTx
Offering hope with a new approach designed to address significant unmet needs At Avalo, our mission is to transform lives with novel therapeutics targeting immune-mediated inflammatory …See details»
Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy …
Jan 2, 2025 WAYNE, Pa. and ROCKVILLE, Md., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the …See details»
Careers - AvaloTx - Avalo Therapeutics, Inc.
Redefining what’s possible in patient care At our core, we’re a biotech company with bold ambitions. We aim to challenge convention, accelerate progress, and reimagine what’s …See details»
FAQ :: Avalo Therapeutics, Inc. (AVTX) - ir.avalotx.com
Where is Avalo's corporate headquarters? Avalo is headquartered at 1500 Liberty Ridge Drive Suite 321 Wayne, PA 19087. The main phone number is (610) 254-4201. Where was Avalo …See details»
Science - AvaloTx
Pioneering novel approaches to unlock the full potential of IL-1β Interleukin-1 beta (IL-1β) is a pro-inflammatory cytokine that plays a central role in the pathogenesis of a wide range of human …See details»
Avalo Therapeutics First Quarter 2022 Financial Results and …
“The first quarter has been highly productive for the Avalo Therapeutics team. We executed our pipeline prioritization plan and right-sized the organization needed to deliver what we think will …See details»
Press Releases - AvaloTx
May 27, 2025 Press Releases Publications Events and Presentations Press releases 202520242023 May 27, 2025 Avalo Therapeutics to Participate in Upcoming Investor …See details»